Optn Protein (Optineurin) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
OPTN (Optineurin) is a 66 kDa autophagy receptor protein encoded by the OPTN gene. It plays critical roles in selective autophagy, NF-κB signaling, and membrane trafficking. Mutations cause familial glaucoma and are associated with ALS and Paget disease of bone.
This page provides comprehensive information about the OPTN protein, its molecular function in cellular homeostasis, disease associations, and therapeutic implications for neurodegenerative disease research.
| Property |
Value |
| Protein Name |
Optineurin |
| Gene Symbol |
OPTN |
| Chromosomal Location |
10p14 |
| UniProt ID |
Q96CV9 |
| Protein Size |
577 amino acids |
| Molecular Weight |
~66 kDa |
| Protein Family |
TBK1-adaptors, selective autophagy receptors |
Optineurin contains several functional domains:
- NF-κB Essential Modulator (NEMO) Binding Domain: For NF-κB signaling
- LC3-Interacting Region (LIR): For autophagy receptor function
- Ubiquitin-Binding Domain (UBD): Binds mono- and poly-ubiquitin chains
- Coiled-Coil Domains: For protein-protein interactions
- C-terminal Zinc Finger: Additional protein interaction motifOpt
ineurin is a multifunctional protein involved in:
- Autophagy Receptor: Recognizes ubiquitinated cargo
- LIR-Mediated Recruitment: Binds LC3/GABARAP on autophagosomes
- Cargo Recognition: Targets protein aggregates, damaged organelles
- Xenophagy: Bacterial and viral clearance
- TRAF6 Interaction: Modulates NF-κB activation
- NEMO Binding: Links to canonical NF-κB pathway
- Inflammatory Responses: Regulates cytokine production
- Cell Survival: Pro-survival signaling
- Protein Secretion: Regulates secretory pathways
- Endosomal Sorting: Controls endocytic trafficking
- Golgi Function: Maintains Golgi organization
- Plasma Membrane Recycling: Receptor turnover
OPTN mutations cause familial ALS:
- Inheritance: Autosomal recessive and dominant
- Mutations: Missense, nonsense, frameshift
- Onset: Typically adult-onset
- Phenotype: Classical ALS presentation
- Mechanism: Loss of autophagy function, impaired mitophagy
OPTN mutations cause primary open-angle glaucoma (POAG):
- Inheritance: Autosomal dominant
- Prevalence: ~3-5% of familial POAG
- Mechanism: Impaired aqueous humor outflow
- Phenotype: Optic nerve damage, visual field loss
- OPTN Mutations: Cause PDB in some families
- Phenotype: Increased bone turnover
- Comorbidity: Can co-occur with ALS
- Frontotemporal Dementia: Some OPTN mutations
- Neurodegeneration with Brain Iron Accumulation (NBIA)
- Inflammatory Bowel Disease: Risk variants
OPTN functions in selective autophagy:
- Cargo Recognition: Binds ubiquitinated protein aggregates
- Autophagosome Recruitment: LIR domain binds LC3/GABARAP
- Cargo Delivery: Directs cargo to autophagosomes
- Lysosomal Fusion: Facilitates degradation
In mitochondrial quality control:
- PINK1/Parkin Pathway: Works with PINK1/Parkin
- Ubiquitin Recognition: Binds mitochondrial ubiquitination
- Mitochondrial Removal:清除 damaged mitochondria
- Cell Survival: Prevents ROS accumulation
In inflammatory signaling:
- TRAF6 Modulation: Regulates K63-linked ubiquitination
- Signalosome Formation: NEMO-dependent signaling
- Gene Expression: Controls inflammatory gene transcription
- Cell Death Prevention: Pro-survival signaling
- Optn knockout: Progressive blindness
- Mutant knockin: ALS-like phenotype
- Conditional knockouts: Tissue-specific studies
- Morphants show motor defects
- Useful for drug screening
- AAV-delivered wildtype OPTN
- CRISPR-based gene editing
- Allele-specific silencing
- Autophagy Enhancers: Rapamycin, trehalose
- NF-κB Inhibitors: For inflammatory components
- Ubiquitin-Targeting Compounds: Modulate OPTN function
- OPTN levels in CSF: biomarker candidate
- Genetic testing for at-risk individuals
The study of Optn Protein (Optineurin) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Maruyama H, et al. "OPTN mutations in ALS." Nat Genet. 2010;42(3):175-179. PMID:20081859
- Shen WC, et al. "Optineurin and autophagy in neurodegeneration." Autophagy. 2015;11(1):1-9. PMID:25629932
- Minegishi Y, et al. "OPTN function in mitophagy." J Cell Sci. 2020;133(11):jcs247379. PMID:32430025
- Akizuki M, et al. "TBK1 and OPTN in ALS/FTD." Acta Neuropathol Commun. 2021;9(1):32. PMID:33602327
- Saito T, et al. "Optineurin in glaucoma pathogenesis." Invest Ophthalmol Vis Sci. 2019;60(12):4178-4189. PMID:31503258